Investing in Stocks Made Easy!
at ₹0 Brokerage with 5paisa.
+91
By proceeding, you agree to all T&C*
Investing in Stocks Made Easy!
We've sent a 6-digit verification code to +91 99123918232
Didn't receive the code? Resend
539730 FREDUN

Fredun Pharmaceuticals Share Price

 

 

Fredun Pharmaceuticals live price: ₹2500. It opened at ₹2,580 vs previous close ₹2,553; intraday high/low: ₹2,620/₹2,475. The 50 & 200 DMA stand at ₹2,089.71/₹1,646.12.

Fredun Pharmaceuticals Performance

  • Today's Low
  • ₹2,475
  • Today's High
  • ₹2,620
  • 52 Week Low
  • ₹690
  • 52 Week High
  • ₹2,620
  • Open Price₹2,580
  • Previous Close₹2,553
  • Volume9,719
  • 50 DMA₹2,089.71
  • 100 DMA₹1,891.70
  • 200 DMA₹1,646.12

Fredun Pharmaceuticals Chart

Investment Returns

  • Over 1 Month + 18.44%
  • Over 3 Month + 49.96%
  • Over 6 Month + 34.17%
  • Over 1 Year + 239.54%

Smart Investing Starts Here Start SIP with Fredun Pharmaceuticals for Steady Growth!

Invest Now

Fredun Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 35
  • PEG Ratio
  • 0.4
  • Market Cap Cr
  • 1,190
  • P/B Ratio
  • 7.1
  • Average True Range
  • 149.87
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • 142.23
  • RSI
  • 66.91
  • MFI
  • 70.49

Latest Stock News Updates

Infomerics Valuation and Rating upgrades Fredun Pharmaceuticals' ratings

Stable outlook reflects improving credit quality amid export expansion across Africa, Southeast Asia, CIS and Latin America

Fredun Pharmaceuticals net doubles to 10 crore, income jumps 35% to 145 crore

First batch of Snacky Jain a Jain functional food for pets sells out through pre-orders

Fredun Pharmaceuticals launches Jain food for pets

Developed through in-house R&D, Snacky Jain combines natural, plant-based ingredients with functional health benefits, ensuring both taste and wellness for companion animals

Fredun Pharmaceuticals Financials

Fredun Pharmaceuticals Technicals

EMA & SMA

Current Price
₹2,500.00
-52.75 (-2.07%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹2,322.64
  • 50 Day
  • ₹2,089.71
  • 100 Day
  • ₹1,891.70
  • 200 Day
  • ₹1,646.12

Resistance and Support

2541.27 Pivot Speed
  • R3 2,752.48
  • R2 2,686.22
  • R1 2,607.53
  • S1 2,462.58
  • S2 2,396.32
  • S3 2,317.63

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Fredun Pharmaceuticals has an operating revenue of Rs. 589.35 Cr. on a trailing 12-month basis. An annual revenue growth of 31% is outstanding, Pre-tax margin of 6% is okay, ROE of 14% is good. The company has a reasonable debt to equity of 7%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 29% and 57% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 31% from the pivot point (which is extended from the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 98 which is a GREAT score indicating consistency in earnings, a RS Rating of 97 which is GREAT indicating the outperformance as compared to other stocks, Buyer Demand at A which is evident from recent demand for the stock, Group Rank of 57 indicates it belongs to a fair industry group of Medical-Diversified and a Master Score of A is the best. Institutional holding has remained stable in the last reported quarter. Overall, the stock has great fundamentals and technical strength to stay in momentum.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Fredun Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-25 Audited Results, Dividend & Bonus issue
2026-02-09 Quarterly Results
2025-11-08 Quarterly Results
2025-09-25 Preferential Issue of shares & Others To consider 1. Issue Of Warrants. alia, to consider a proposal for fund raising up to Rs.120 crores by way of further public offer, rights issue, debt issue, preferential issue or any other method.
2025-07-30 Quarterly Results
Date Purpose Remarks
2025-09-23 FINAL Rs.0.70 per share(7%)Dividend
2024-09-23 FINAL Rs.0.70 per share(7%)Final Dividend
2023-09-22 FINAL Rs.0.70 per share(7%)Final Dividend
2022-09-15 FINAL Rs.0.70 per share(7%)Final Dividend
View Fredun Pharmaceuticals Dividend History Arrow

Fredun Pharmaceuticals Shareholding Pattern

44.57%
1.06%
1.36%
44.33%
8.68%

Fredun Pharmaceuticals FAQs

Fredun Pharmaceuticals share price is ₹2,500 As on 25 May, 2026 | 05:20

The Market Cap of Fredun Pharmaceuticals is ₹1190.4 Cr As on 25 May, 2026 | 05:20

The P/E ratio of Fredun Pharmaceuticals is 35 As on 25 May, 2026 | 05:20

The PB ratio of Fredun Pharmaceuticals is 7.1 As on 25 May, 2026 | 05:20

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23